Skip to main content

Travere Therapeutics, Inc 10-K for FY2024

Travere Therapeutics, Inc. (TVTX)

10-K 2025-02-21 For: 2024-12-31
View Original
Added on April 07, 2026

About this 10-K

Travere Therapeutics, Inc filed this 10-K on February 21, 2025, covering the fiscal year ended December 31, 2024 (FY2024).

Headline figures

Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$233.18M
up 60.5% from $145.24M a year earlier
Net loss
$321.55M
compared with a net loss of $111.4M a year earlier
Diluted EPS
-$4.08
compared with -$1.50 a year earlier